{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T10:29:56Z","timestamp":1785493796858,"version":"3.56.0"},"reference-count":179,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100010146","name":"Alzheimer Forschung Initiative","doi-asserted-by":"publisher","award":["18007"],"award-info":[{"award-number":["18007"]}],"id":[{"id":"10.13039\/100010146","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["125440785 SFB 877"],"award-info":[{"award-number":["125440785 SFB 877"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Cell Research"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.bbamcr.2021.119164","type":"journal-article","created":{"date-parts":[[2021,10,25]],"date-time":"2021-10-25T08:56:12Z","timestamp":1635152172000},"page":"119164","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["The Swedish dilemma - the almost exclusive use of APPswe-based mouse models impedes adequate evaluation of alternative \u03b2-secretases"],"prefix":"10.1016","volume":"1869","author":[{"given":"Fred","family":"Armbrust","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kira","family":"Bickenbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liana","family":"Marengo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claus","family":"Pietrzik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Becker-Pauly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbamcr.2021.119164_bb0005","series-title":"Deaths. Leading Causes for 2017, National Vital Statistics Reports: From the Centers for Disease Control and Prevention","first-page":"1","volume":"68","author":"Heron","year":"2019"},{"key":"10.1016\/j.bbamcr.2021.119164_bb0010","first-page":"27","article-title":"Dementia: a review","volume":"1","author":"Fymat","year":"2018","journal-title":"J. Clin. Psychiatr. Neurosci."},{"key":"10.1016\/j.bbamcr.2021.119164_bb0015","doi-asserted-by":"crossref","DOI":"10.1177\/1179573520907397","article-title":"Current and future treatments in Alzheimer disease. An update","volume":"12","author":"Yiannopoulou","year":"2020","journal-title":"J. Cent. Nerv. Syst. Dis."},{"key":"10.1016\/j.bbamcr.2021.119164_bb0020","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/nature19323","article-title":"The antibody aducanumab reduces A\u03b2 plaques in Alzheimer's disease","volume":"537","author":"Sevigny","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.bbamcr.2021.119164_bb0025","doi-asserted-by":"crossref","first-page":"3069","DOI":"10.1007\/s10072-021-05497-4","article-title":"Alzheimer's disease. The controversial approval of Aducanumab","volume":"42","author":"Tagliavini","year":"2021","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.bbamcr.2021.119164_bb0030","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1126\/science.1566067","article-title":"Alzheimer's disease. The amyloid cascade hypothesis","volume":"256","author":"Hardy","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.bbamcr.2021.119164_bb0035","doi-asserted-by":"crossref","first-page":"595","DOI":"10.15252\/emmm.201606210","article-title":"The amyloid hypothesis of Alzheimer's disease at 25 years","volume":"8","author":"Selkoe","year":"2016","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.bbamcr.2021.119164_bb0040","doi-asserted-by":"crossref","first-page":"245","DOI":"10.4062\/biomolther.2012.20.3.245","article-title":"Mechanisms of amyloid-\u03b2 peptide clearance. Potential therapeutic targets for Alzheimer's disease","volume":"20","author":"Yoon","year":"2012","journal-title":"Biomol. Ther."},{"key":"10.1016\/j.bbamcr.2021.119164_bb0045","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1515\/revneuro-2017-0063","article-title":"Amyloid toxicity in Alzheimer's disease","volume":"29","author":"Reiss","year":"2018","journal-title":"Rev. Neurosci."},{"key":"10.1016\/j.bbamcr.2021.119164_bb0050","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/sj.mp.4000552","article-title":"It all sticks together\u2013the APP-related family of proteins and Alzheimer's disease","volume":"4","author":"Bayer","year":"1999","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.bbamcr.2021.119164_bb0055","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.exger.2012.07.009","article-title":"Expression and function of APP and its metabolites outside the central nervous system","volume":"48","author":"Puig","year":"2013","journal-title":"Exp. Gerontol."},{"key":"10.1016\/j.bbamcr.2021.119164_bb0060","first-page":"161","article-title":"Novel insights into the physiological function of the APP (gene) family and its proteolytic fragments in synaptic plasticity","volume":"9","author":"Ludewig","year":"2016","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.bbamcr.2021.119164_bb0065","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.neuron.2020.08.011","article-title":"APP family regulates neuronal excitability and synaptic plasticity but not neuronal survival","volume":"108","author":"Lee","year":"2020","journal-title":"Neuron"},{"key":"10.1016\/j.bbamcr.2021.119164_bb0070","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1756-6606-4-3","article-title":"APP processing in Alzheimer's disease","volume":"4","author":"Zhang","year":"2011","journal-title":"Mol. Brain"},{"key":"10.1016\/j.bbamcr.2021.119164_bb0075","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/0006-291X(90)90992-V","article-title":"Differential splicing of Alzheimer's disease amyloid A4 precursor RNA in rat tissues. PreA4695 mRNA is predominantly produced in rat and human brain","author":"Kang","year":"1990","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbamcr.2021.119164_bb0080","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1038\/aps.2017.28","article-title":"Amyloid beta. Structure, biology and structure-based therapeutic development","volume":"38","author":"Chen","year":"2017","journal-title":"Acta Pharmacologica Sinica"},{"key":"10.1016\/j.bbamcr.2021.119164_bb0085","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1074\/jbc.271.3.1613","article-title":"Regulation of amyloid protein precursor (APP) binding to collagen and mapping of the binding sites on APP and collagen type I","volume":"271","author":"Beher","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamcr.2021.119164_bb0090","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/jnc.14122","article-title":"The physiological role of the amyloid precursor protein as an adhesion molecule in the developing nervous system","volume":"143","author":"Sosa","year":"2017","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbamcr.2021.119164_bb0095","series-title":"Proceedings of the National Academy of Sciences of the United States of America 97","first-page":"1456","article-title":"Human aspartic protease memapsin 2 cleaves the beta-secretase site of beta-amyloid precursor protein","author":"Lin","year":"2000"},{"key":"10.1016\/j.bbamcr.2021.119164_bb0100","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1006\/mcne.1999.0811","article-title":"Identification of a novel aspartic protease (Asp 2) as beta-secretase","volume":"14","author":"Hussain","year":"1999","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.bbamcr.2021.119164_bb0105","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/990114","article-title":"Purification and cloning of amyloid precursor protein beta-secretase from human brain","volume":"402","author":"Sinha","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.bbamcr.2021.119164_bb0110","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/990107","article-title":"Membrane-anchored aspartyl protease with Alzheimer's disease beta-secretase activity","volume":"402","author":"Yan","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.bbamcr.2021.119164_bb0115","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1126\/science.286.5440.735","article-title":"Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE","volume":"286","author":"Vassar","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.bbamcr.2021.119164_bb0120","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/B978-0-12-394816-8.00004-0","article-title":"\u03b3-Secretase as a target for Alzheimer's disease","volume":"64","author":"Wolfe","year":"2012","journal-title":"Adv. Pharmacol."},{"key":"10.1016\/j.bbamcr.2021.119164_bb0125","first-page":"105","article-title":"he non-amyloidogenic pathway. Structure and function of alpha-secretases","volume":"38","author":"Kojro","year":"2005"},{"key":"10.1016\/j.bbamcr.2021.119164_bb0130","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0006-291X(02)02999-6","article-title":"Putative function of ADAM9, ADAM10, and ADAM17 as APP -secretase","volume":"301","author":"Asai","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbamcr.2021.119164_bb0135","doi-asserted-by":"crossref","first-page":"3020","DOI":"10.1038\/emboj.2010.167","article-title":"ADAM10 is the physiologically relevant, constitutive alpha-secretase of the amyloid precursor protein in primary neurons","volume":"29","author":"Kuhn","year":"2010","journal-title":"EMBO J."},{"key":"10.1016\/j.bbamcr.2021.119164_bb0140","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1750-1326-2-22","article-title":"The Alzheimer's disease beta-secretase enzyme, BACE1","volume":"2","author":"Cole","year":"2007","journal-title":"Mol. Neurodegener."},{"issue":"Pt 11","key":"10.1016\/j.bbamcr.2021.119164_bb0145","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1242\/jcs.113.11.1857","article-title":"Proteolytic processing and cell biological functions of the amyloid precursor protein","volume":"113","author":"De Strooper","year":"2000","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.bbamcr.2021.119164_bb0150","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1016\/S0169-409X(02)00157-6","article-title":"\u03b2-secretase (BACE) as a drug target for Alzheimer's disease","volume":"54","author":"Vassar","year":"2002","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.bbamcr.2021.119164_bb0155","doi-asserted-by":"crossref","first-page":"16278","DOI":"10.1074\/jbc.M111141200","article-title":"Beta-secretase processing in the trans-Golgi network preferentially generates truncated amyloid species that accumulate in Alzheimer's disease brain","volume":"277","author":"Huse","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamcr.2021.119164_bb0160","doi-asserted-by":"crossref","first-page":"24041","DOI":"10.1074\/jbc.M116.744722","article-title":"Alternative selection of \u03b2-site APP-cleaving enzyme 1 (BACE1) cleavage sites in amyloid \u03b2-protein precursor (APP) harboring protective and pathogenic mutations within the A\u03b2 sequence","volume":"291","author":"Kimura","year":"2016","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamcr.2021.119164_bb0165","doi-asserted-by":"crossref","first-page":"3128","DOI":"10.1021\/bi015800g","article-title":"Glu11 site cleavage and N-terminally truncated a beta production upon BACE overexpression","volume":"41","author":"Liu","year":"2002","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbamcr.2021.119164_bb0170","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/85064","article-title":"BACE1 is the major beta-secretase for generation of Abeta peptides by neurons","volume":"4","author":"Cai","year":"2001","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.bbamcr.2021.119164_bb0175","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1111\/j.1471-4159.2006.04178.x","article-title":"BACE1 inhibition reduces endogenous abeta and alters APP processing in wild-type mice","volume":"99","author":"Nishitomi","year":"2006","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbamcr.2021.119164_bb0180","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1001\/archneur.59.9.1381","article-title":"Beta-secretase protein and activity are increased in the neocortex in Alzheimer disease","volume":"59","author":"Fukumoto","year":"2002","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.bbamcr.2021.119164_bb0185","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1002\/ana.10208","article-title":"Increased expression of the amyloid precursor beta-secretase in Alzheimer's disease","volume":"51","author":"Holsinger","year":"2002","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbamcr.2021.119164_bb0190","series-title":"Proc.Natl. Acad.Sci.USA 101","first-page":"3632","article-title":"Amyloid beta peptide load is correlated with increased beta-secretase activity in sporadic Alzheimer's disease patients","author":"Li","year":"2004"},{"key":"10.1016\/j.bbamcr.2021.119164_bb0195","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.neuroscience.2006.08.027","article-title":"High sensitivity analysis of amyloid-beta peptide composition in amyloid deposits from human and PS2APP mouse brain","volume":"143","author":"G\u00fcntert","year":"2006","journal-title":"Neuroscience"},{"key":"10.1016\/j.bbamcr.2021.119164_bb0200","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1002\/j.1460-2075.1985.tb04000.x","article-title":"Neuronal origin of a cerebral amyloid. Neurofibrillary tangles of Alzheimer's disease contain the same protein as the amyloid of plaque cores and blood vessels","volume":"4","author":"Masters","year":"1985","journal-title":"EMBO J."},{"key":"10.1016\/j.bbamcr.2021.119164_bb0205","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1006\/bbrc.2000.3490","article-title":"Amyloid beta protein starting pyroglutamate at position 3 is a major component of the amyloid deposits in the Alzheimer's disease brain","volume":"276","author":"Harigaya","year":"2000","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbamcr.2021.119164_bb0210","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/0896-6273(95)90301-1","article-title":"Dominant and differential deposition of distinct \u03b2-amyloid peptide species, A\u03b2N3(pE), in senile plaques","volume":"14","author":"Saido","year":"1995","journal-title":"Neuron"},{"key":"10.1016\/j.bbamcr.2021.119164_bb0215","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s13024-016-0084-5","article-title":"Generation of aggregation prone N-terminally truncated amyloid \u03b2 peptides by meprin \u03b2 depends on the sequence specificity at the cleavage site","volume":"11","author":"Sch\u00f6nherr","year":"2016","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.bbamcr.2021.119164_bb0220","doi-asserted-by":"crossref","first-page":"14412","DOI":"10.1002\/chem.201002878","article-title":"Structural design, solid-phase synthesis and activity of membrane-anchored \u03b2-secretase inhibitors on A\u03b2 generation from wild-type and Swedish-mutant APP","volume":"16","author":"Schieb","year":"2010","journal-title":"Chemistry"},{"key":"10.1016\/j.bbamcr.2021.119164_bb0225","doi-asserted-by":"crossref","first-page":"12787","DOI":"10.1523\/JNEUROSCI.3657-09.2009","article-title":"The beta-secretase enzyme BACE in health and Alzheimer's disease. Regulation, cell biology, function, and therapeutic potential","volume":"29","author":"Vassar","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbamcr.2021.119164_bb0230","doi-asserted-by":"crossref","first-page":"42645","DOI":"10.1074\/jbc.M102790200","article-title":"Elevation of beta-amyloid peptide 2\u201342 in sporadic and familial Alzheimer's disease and its generation in PS1 knockout cells","volume":"276","author":"Wiltfang","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamcr.2021.119164_bb0235","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0006-8993(96)00002-9","article-title":"Effect of alkalizing agents on the processing of the beta-amyloid precursor protein","volume":"716","author":"Schrader-Fischer","year":"1996","journal-title":"Brain Res."},{"key":"10.1016\/j.bbamcr.2021.119164_bb0240","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1096\/fj.03-1070fje","article-title":"Amino-truncated amyloid beta-peptide (Abeta5-40\/42) produced from caspase-cleaved amyloid precursor protein is deposited in Alzheimer's disease brain","volume":"18","author":"Takeda","year":"2004","journal-title":"FASEB J.ournal : official publication of the Federation of American Societies for Experimental Biology"},{"key":"10.1016\/j.bbamcr.2021.119164_bb0245","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0031084","article-title":"BACE1 inhibition induces a specific cerebrospinal fluid \u03b2-amyloid pattern that identifies drug effects in the central nervous system","volume":"7","author":"Mattsson","year":"2012","journal-title":"PloS one"},{"key":"10.1016\/j.bbamcr.2021.119164_bb0250","doi-asserted-by":"crossref","first-page":"33304","DOI":"10.1074\/jbc.M112.395608","article-title":"The metalloprotease meprin \u03b2 generates amino terminal-truncated amyloid \u03b2 peptide species","volume":"287","author":"Bien","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamcr.2021.119164_bb0255","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3233\/JAD-131370","article-title":"Brain pyroglutamate amyloid-\u03b2 is produced by cathepsin B and is reduced by the cysteine protease inhibitor E64d, representing a potential Alzheimer's disease therapeutic","volume":"41","author":"Hook","year":"2014","journal-title":"Journal of Alzheimer's disease : JAD"},{"key":"10.1016\/j.bbamcr.2021.119164_bb0260","doi-asserted-by":"crossref","first-page":"7745","DOI":"10.1074\/jbc.M708362200","article-title":"Inhibitors of cathepsin B improve memory and reduce beta-amyloid in transgenic alzheimer disease mice expressing the wild-type, but not the swedish mutant, beta-secretase site of the amyloid precursor protein","volume":"283","author":"Hook","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamcr.2021.119164_bb0265","article-title":"The role of cathepsin B in the degradation of A\u03b2 and in the production of A\u03b2 peptides starting with Ala2 in cultured astrocytes","volume":"13","author":"Oberstein","year":"2020","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.bbamcr.2021.119164_bb0270","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s00401-018-1929-5","article-title":"The metalloprotease ADAMTS4 generates N-truncated A\u03b24-x species and marks oligodendrocytes as a source of amyloidogenic peptides in Alzheimer's disease","volume":"137","author":"Walter","year":"2019","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.bbamcr.2021.119164_bb0275","series-title":"The ins and outs of cathepsins. Physiological function and role in disease management","author":"Yadati","year":"2020"},{"key":"10.1016\/j.bbamcr.2021.119164_bb0280","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1046\/j.1432-1327.1999.00582.x","article-title":"Exocytosis of active cathepsin B enzyme activity at pH 7.0, inhibition and molecular mass","volume":"264","author":"Linebaugh","year":"1999","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.bbamcr.2021.119164_bb0285","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3233\/JAD-2005-7205","article-title":"Quantitative proteomics of cerebrospinal fluid from patients with Alzheimer disease","volume":"7","author":"Zhang","year":"2005","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.bbamcr.2021.119164_bb0290","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbapap.2020.140428","article-title":"Cathepsin B in neurodegeneration of Alzheimer's disease, traumatic brain injury, and related brain disorders, biochimica et biophysica acta","volume":"1868","author":"Hook","year":"2020","journal-title":"Proteins and proteomics"},{"key":"10.1016\/j.bbamcr.2021.119164_bb0295","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/s13059-015-0676-3","article-title":"The ADAMTS (A disintegrin and metalloproteinase with thrombospondin motifs) family","volume":"16","author":"Kelwick","year":"2015","journal-title":"Genome Biol."},{"key":"10.1016\/j.bbamcr.2021.119164_bb0300","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/j.1471-4159.2009.05950.x","article-title":"Aminopeptidase A contributes to the N-terminal truncation of amyloid beta-peptide","volume":"109","author":"Sevalle","year":"2009","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbamcr.2021.119164_bb0305","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1007\/s00401-021-02308-0","article-title":"Aminopeptidase A contributes to biochemical, anatomical and cognitive defects in Alzheimer's disease (AD) mouse model and is increased at early stage in sporadic AD brain","volume":"141","author":"Valverde","year":"2021","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.bbamcr.2021.119164_bb0310","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1006\/bbrc.1996.5920","article-title":"Reduction of plasma glutamyl aminopeptidase activity in sporadic Alzheimer's disease","volume":"231","author":"Kuda","year":"1997","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbamcr.2021.119164_bb0315","series-title":"Dement. Geriatr. Cognit. Disord. 9","first-page":"44","article-title":"Alanyl-aminopeptidase activity decrease in cerebrospinal fluid of Alzheimer patients","author":"Iribar","year":"1998"},{"key":"10.1016\/j.bbamcr.2021.119164_bb0320","doi-asserted-by":"crossref","first-page":"203","DOI":"10.3233\/JAD-161265","article-title":"Angiotensin-III is increased in Alzheimer's disease in association with amyloid-\u03b2 and tau pathology","volume":"58","author":"Kehoe","year":"2017","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.bbamcr.2021.119164_bb0325","doi-asserted-by":"crossref","first-page":"359","DOI":"10.3233\/JAD-171183","article-title":"Dipeptidyl-peptidase activity of meprin \u03b2 links N-truncation of A\u03b2 with glutaminyl cyclase-catalyzed pGlu-A\u03b2 formation","volume":"66","author":"Schlenzig","year":"2018","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.bbamcr.2021.119164_bb0330","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1111\/nan.12452","article-title":"Whole-exome sequencing of the BDR cohort. Evidence to support the role of the PILRA gene in Alzheimer's disease","volume":"44","author":"Patel","year":"2018","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.bbamcr.2021.119164_bb0335","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1083\/jcb.201806205","article-title":"A cellular complex of BACE1 and \u03b3-secretase sequentially generates A\u03b2 from its full-length precursor","volume":"218","author":"Liu","year":"2019","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.bbamcr.2021.119164_bb0340","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/325733a0","article-title":"The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor","volume":"325","author":"Kang","year":"1987","journal-title":"Nature"},{"key":"10.1016\/j.bbamcr.2021.119164_bb0345","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s00221-011-2870-1","article-title":"Axonal transport of APP and the spatial regulation of APP cleavage and function in neuronal cells","volume":"217","author":"Brunholz","year":"2012","journal-title":"Exp. Brain Res."},{"key":"10.1016\/j.bbamcr.2021.119164_bb0350","doi-asserted-by":"crossref","first-page":"14534","DOI":"10.1523\/JNEUROSCI.1546-09.2009","article-title":"APP anterograde transport requires Rab3A GTPase activity for assembly of the transport vesicle","volume":"29","author":"Szodorai","year":"2009","journal-title":"the journal of neuroscience : the official journal of the society forNeuroscience"},{"key":"10.1016\/j.bbamcr.2021.119164_bb0355","doi-asserted-by":"crossref","first-page":"3565","DOI":"10.1074\/jbc.270.8.3565","article-title":"Characterization of sorting signals in the \u03b2-amyloid precursor protein cytoplasmic domain","volume":"270","author":"Lai","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamcr.2021.119164_bb0360","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/nn.4188","article-title":"Visualizing APP and BACE-1 approximation in neurons yields insight into the amyloidogenic pathway","volume":"19","author":"Das","year":"2016","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.bbamcr.2021.119164_bb0365","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a006270","article-title":"Trafficking and proteolytic processing of APP","volume":"2","author":"Haass","year":"2012","journal-title":"Cold Spring Harb.Perspect.Med."},{"key":"10.1016\/j.bbamcr.2021.119164_bb0370","first-page":"2751","article-title":"Sorting receptor SORLA\u2013a trafficking path to avoid alzheimer disease","volume":"126","author":"Willnow","year":"2013","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.bbamcr.2021.119164_bb0375","first-page":"500","article-title":"Targeting of cell-surface beta-amyloid precursor protein to lysosomes.Alternative processing into amyloid-bearing fragments","volume":"357","author":"Haass","year":"1992"},{"key":"10.1016\/j.bbamcr.2021.119164_bb0380","doi-asserted-by":"crossref","first-page":"3339","DOI":"10.1242\/jcs.00643","article-title":"Demonstration by FRET of BACE interaction with the amyloid precursor protein at the cell surface and in early endosomes","volume":"116","author":"Kinoshita","year":"2003","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.bbamcr.2021.119164_bb0385","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1146\/annurev-neuro-061010-113613","article-title":"Amyloid precursor protein processing and Alzheimer's disease","volume":"34","author":"O'Brien","year":"2011","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.bbamcr.2021.119164_bb0390","first-page":"10879","article-title":"Post-translational processing of beta-secretase (beta-amyloid-converting enzyme) and its ectodomain shedding.The pro- and transmembrane\/cytosolic domains affect its cellular activity and amyloid-beta production","volume":"276","author":"Benjannet","year":"2001"},{"key":"10.1016\/j.bbamcr.2021.119164_bb0395","doi-asserted-by":"crossref","first-page":"37712","DOI":"10.1074\/jbc.M005339200","article-title":"A furin-like convertase mediates propeptide cleavage of BACE, the Alzheimer's beta -secretase","volume":"275","author":"Bennett","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamcr.2021.119164_bb0400","doi-asserted-by":"crossref","first-page":"4211","DOI":"10.1074\/jbc.M006947200","article-title":"Processing of beta-secretase by furin and other members of the proprotein convertase family","volume":"276","author":"Creemers","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamcr.2021.119164_bb0405","doi-asserted-by":"crossref","first-page":"10366","DOI":"10.1074\/jbc.M009200200","article-title":"The pro domain of beta-secretase does not confer strict zymogen-like properties but does assist proper folding of the protease domain","volume":"276","author":"Shi","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamcr.2021.119164_bb0410","doi-asserted-by":"crossref","first-page":"21099","DOI":"10.1074\/jbc.M002095200","article-title":"Characterization of Alzheimer's beta -secretase protein BACE. A pepsin family member with unusual properties","volume":"275","author":"Haniu","year":"2000","journal-title":"J.Biol.Chem."},{"key":"10.1016\/j.bbamcr.2021.119164_bb0415","doi-asserted-by":"crossref","first-page":"30849","DOI":"10.1074\/jbc.M003202200","article-title":"Maturation and pro-peptide cleavage of beta-secretase","volume":"275","author":"Capell","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamcr.2021.119164_bb0420","doi-asserted-by":"crossref","first-page":"16739","DOI":"10.1074\/jbc.M009361200","article-title":"Characterization of the glycosylation profiles of Alzheimer's beta -secretase protein Asp-2 expressed in a variety of cell lines","volume":"276","author":"Charlwood","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamcr.2021.119164_bb0425","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1042\/BJ20070040","article-title":"A reversible form of lysine acetylation in the ER and Golgi lumen controls the molecular stabilization of BACE1","volume":"407","author":"Costantini","year":"2007","journal-title":"Biochem. J."},{"key":"10.1016\/j.bbamcr.2021.119164_bb0430","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1046\/j.0022-3042.2002.00806.x","article-title":"The disulphide bonds in the catalytic domain of BACE are critical but not essential for amyloid precursor protein processing activity","volume":"80","author":"Fischer","year":"2002","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbamcr.2021.119164_bb0435","doi-asserted-by":"crossref","first-page":"39710","DOI":"10.1074\/jbc.M402785200","article-title":"Human BACE forms dimers and colocalizes with APP","volume":"279","author":"Schmechel","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamcr.2021.119164_bb0440","doi-asserted-by":"crossref","first-page":"53205","DOI":"10.1074\/jbc.M410378200","article-title":"Dimerization of beta-site beta-amyloid precursor protein-cleaving enzyme","volume":"279","author":"Westmeyer","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamcr.2021.119164_bb0445","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1006\/mcne.2001.1065","article-title":"The carboxyl-terminus of BACE contains a sorting signal that regulates BACE trafficking but not the formation of total A(beta)","volume":"19","author":"Pastorino","year":"2002","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.bbamcr.2021.119164_bb0450","doi-asserted-by":"crossref","first-page":"17386","DOI":"10.1016\/S0021-9258(17)32449-3","article-title":"Evidence that production and release of amyloid beta-protein involves the endocytic pathway","volume":"269","author":"Koo","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamcr.2021.119164_bb0455","series-title":"Proc. Natl. Acad. Sci.USA 103","first-page":"11172","article-title":"Alzheimer's disease beta-amyloid peptides are released in association with exosomes","author":"Rajendran","year":"2006"},{"key":"10.1016\/j.bbamcr.2021.119164_bb0460","doi-asserted-by":"crossref","DOI":"10.15252\/embr.201947954","article-title":"AP-2 reduces amyloidogenesis by promoting BACE1 trafficking and degradation in neurons","volume":"21","author":"Bera","year":"2020","journal-title":"EMBO Rep."},{"key":"10.1016\/j.bbamcr.2021.119164_bb0465","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1111\/tra.12088","article-title":"Intracellular itinerary of internalised \u03b2-secretase, BACE1, and its potential impact on \u03b2-amyloid peptide biogenesis","volume":"14","author":"Chia","year":"2013","journal-title":"Traffic"},{"key":"10.1016\/j.bbamcr.2021.119164_bb0470","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1091\/mbc.e11-11-0944","article-title":"Adaptor protein 2-mediated endocytosis of the \u03b2-secretase BACE1 is dispensable for amyloid precursor protein processing","volume":"23","author":"Prabhu","year":"2012","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.bbamcr.2021.119164_bb0475","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.neurobiolaging.2017.08.024","article-title":"Par3 and aPKC regulate BACE1 endosome-to-TGN trafficking through PACS1","volume":"60","author":"Sun","year":"2017","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.bbamcr.2021.119164_bb0480","doi-asserted-by":"crossref","first-page":"14634","DOI":"10.1074\/jbc.M011116200","article-title":"Phosphorylation regulates intracellular trafficking of beta-secretase","volume":"276","author":"Walter","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamcr.2021.119164_bb0485","doi-asserted-by":"crossref","first-page":"11696","DOI":"10.1074\/jbc.M411296200","article-title":"GGA proteins mediate the recycling pathway of memapsin 2 (BACE)","volume":"280","author":"He","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamcr.2021.119164_bb0490","doi-asserted-by":"crossref","first-page":"5437","DOI":"10.1242\/jcs.01422","article-title":"Demonstration of BACE (beta-secretase) phosphorylation and its interaction with GGA1 in cells by fluorescence-lifetime imaging microscopy","volume":"117","author":"von Arnim","year":"2004","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.bbamcr.2021.119164_bb0495","doi-asserted-by":"crossref","first-page":"12838","DOI":"10.1523\/JNEUROSCI.1982-06.2006","article-title":"GGA1 is expressed in the human brain and affects the generation of amyloid beta-peptide","volume":"26","author":"Wahle","year":"2006","journal-title":"the journal of neuroscience : the official journal of the society forNeuroscience"},{"key":"10.1016\/j.bbamcr.2021.119164_bb0500","doi-asserted-by":"crossref","first-page":"9913","DOI":"10.1523\/JNEUROSCI.2290-06.2006","article-title":"GGA1 acts as a spatial switch altering amyloid precursor protein trafficking and processing","volume":"26","author":"von Arnim","year":"2006","journal-title":"the journal of neuroscience : the official journal of the society forNeuroscience"},{"key":"10.1016\/j.bbamcr.2021.119164_bb0505","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.bbrc.2005.10.015","article-title":"Extracellular release of BACE1 holoproteins from human neuronal cells","volume":"338","author":"Murayama","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbamcr.2021.119164_bb0510","doi-asserted-by":"crossref","first-page":"36264","DOI":"10.1074\/jbc.M304186200","article-title":"Characterization of the ectodomain shedding of the beta-site amyloid precursor protein-cleaving enzyme 1 (BACE1)","volume":"278","author":"Hussain","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamcr.2021.119164_bb0515","series-title":"Proc.Natl. Acad.Sci. USA109","first-page":"16131","article-title":"Structural basis for the sheddase function of human meprin \u03b2 metalloproteinase at the plasma membrane","author":"Arolas","year":"2012"},{"key":"10.1016\/j.bbamcr.2021.119164_bb0520","first-page":"159","article-title":"The metalloprotease meprin \u03b2 is an alternative \u03b2-secretase of APP","volume":"9","author":"Becker-Pauly","year":"2016","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.bbamcr.2021.119164_bb0525","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1038\/jid.2010.202","article-title":"Processing of procollagen III by meprins. New players in extracellular matrix assembly?","volume":"130","author":"Kronenberg","year":"2010","journal-title":"J. Investig. Dermatol."},{"key":"10.1016\/j.bbamcr.2021.119164_bb0530","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1038\/sj.jid.5700675","article-title":"The alpha and beta subunits of the metalloprotease meprin are expressed in separate layers of human epidermis, revealing different functions in keratinocyte proliferation and differentiation","volume":"127","author":"Becker-Pauly","year":"2007","journal-title":"J.Investig. Dermatol."},{"key":"10.1016\/j.bbamcr.2021.119164_bb0535","doi-asserted-by":"crossref","first-page":"31371","DOI":"10.1074\/jbc.M802814200","article-title":"Prointerleukin-18 is activated by meprin beta in vitro and in vivo in intestinal inflammation","volume":"283","author":"Banerjee","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamcr.2021.119164_bb0540","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.bbrc.2008.12.161","article-title":"Meprin a and meprin alpha generate biologically functional IL-1beta from pro-IL-1beta","volume":"379","author":"Herzog","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbamcr.2021.119164_bb0545","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1046\/j.1432-1327.1999.00071.x","article-title":"Secretion of human meprin from intestinal epithelial cells depends on differential expression of the alpha and beta subunits","volume":"259","author":"Lottaz","year":"1999","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.bbamcr.2021.119164_bb0550","series-title":"Role of meprins to protect ileal mucosa of Crohn's disease patients from colonization by adherent-invasive E. coli","author":"Vazeille","year":"2011"},{"key":"10.1016\/j.bbamcr.2021.119164_bb0555","doi-asserted-by":"crossref","first-page":"4276","DOI":"10.1002\/pmic.200900402","article-title":"A guide to the proteomics identifications database proteomics data repository","volume":"9","author":"Vizca\u00edno","year":"2009","journal-title":"Proteomics"},{"key":"10.1016\/j.bbamcr.2021.119164_bb0560","doi-asserted-by":"crossref","DOI":"10.1074\/mcp.M111.009233","article-title":"Proteomic analyses reveal an acidic prime side specificity for the astacin metalloprotease family reflected by physiological substrates","volume":"10","author":"Becker-Pauly","year":"2011","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.bbamcr.2021.119164_bb0565","doi-asserted-by":"crossref","first-page":"7490","DOI":"10.1096\/fj.201802391R","article-title":"Tethering soluble meprin \u03b1 in an enzyme complex to the cell surface affects IBD-associated genes","volume":"33","author":"Peters","year":"2019","journal-title":"FASEB journal : official publication of the Federation of American Societies forExp. Biol."},{"key":"10.1016\/j.bbamcr.2021.119164_bb0570","doi-asserted-by":"crossref","first-page":"17350","DOI":"10.1016\/S0021-9258(19)47380-8","article-title":"Meprin-A and -B. Cell surface endopeptidases of the mouse kidney","volume":"266","author":"Kounnas","year":"1991","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamcr.2021.119164_bb0575","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1042\/BJ20141417","article-title":"Metalloprotease meprin \u03b2 is activated by transmembrane serine protease matriptase-2 at the cell surface thereby enhancing APP shedding","volume":"470","author":"J\u00e4ckle","year":"2015","journal-title":"Biochem. J."},{"key":"10.1016\/j.bbamcr.2021.119164_bb0580","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1515\/bc.2010.023","article-title":"Analyzing the protease web in skin. Meprin metalloproteases are activated specifically by KLK4, 5 and 8 vice versa leading to processing of proKLK7 thereby triggering its activation","volume":"391","author":"Ohler","year":"2010","journal-title":"Biol. Chem."},{"key":"10.1016\/j.bbamcr.2021.119164_bb0585","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s00018-012-1106-2","article-title":"The substrate degradome of meprin metalloproteases reveals an unexpected proteolytic link between meprin \u03b2 and ADAM10","volume":"70","author":"Jefferson","year":"2013","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.bbamcr.2021.119164_bb0590","doi-asserted-by":"crossref","first-page":"42829","DOI":"10.1074\/jbc.M211169200","article-title":"Phorbol 12-myristate 13-acetate-induced ectodomain shedding and phosphorylation of the human meprinbeta metalloprotease","volume":"278","author":"Hahn","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamcr.2021.119164_bb0595","doi-asserted-by":"crossref","first-page":"11925","DOI":"10.1096\/fj.201801371R","article-title":"Meprin \u03b2 induces activities of a disintegrin and metalloproteinases 9, 10, and 17 by specific prodomain cleavage","volume":"33","author":"Wichert","year":"2019","journal-title":"FASEB journal : official publication of the Federation of American Societies forExp. Biol."},{"key":"10.1016\/j.bbamcr.2021.119164_bb0600","series-title":"Proc.Natl. Acad. Sci. USA111","first-page":"12396","article-title":"Microbial-induced meprin \u03b2 cleavage in MUC2 mucin and a functional CFTR channel are required to release anchored small intestinal mucus","author":"Sch\u00fctte","year":"2014"},{"key":"10.1016\/j.bbamcr.2021.119164_bb0605","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1016\/j.bbamcr.2017.05.011","article-title":"Meprin metalloproteases. Molecular regulation and function in inflammation and fibrosis","volume":"1864","author":"Arnold","year":"2017","journal-title":"Biochim. Biophys. Acta Mol. Cell Res."},{"key":"10.1016\/j.bbamcr.2021.119164_bb0610","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202100271R","article-title":"Phosphorylation of meprin \u03b2 controls its cell surface abundance and subsequently diminishes ectodomain shedding","volume":"35","author":"Armbrust","year":"2021","journal-title":"FASEB J."},{"key":"10.1016\/j.bbamcr.2021.119164_bb0615","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2023839118","article-title":"The crystal structure of a 250-kDa heterotetrameric particle explains inhibition of sheddase meprin \u03b2 by endogenous fetuin-B","volume":"118","author":"Eckhard","year":"2021","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbamcr.2021.119164_bb0620","doi-asserted-by":"crossref","first-page":"8599","DOI":"10.1021\/bi1004238","article-title":"Fetuin-A and cystatin C are endogenous inhibitors of human meprin metalloproteases","volume":"49","author":"Hedrich","year":"2010","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbamcr.2021.119164_bb0625","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1038\/s41598-018-37024-5","article-title":"Mammalian plasma fetuin-B is a selective inhibitor of ovastacin and meprin metalloproteinases","volume":"9","author":"Karmilin","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbamcr.2021.119164_bb0630","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.molbrainres.2003.08.005","article-title":"Proteomic studies of potential cerebrospinal fluid protein markers for Alzheimer's disease","volume":"118","author":"Puchades","year":"2003","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.bbamcr.2021.119164_bb0635","doi-asserted-by":"crossref","first-page":"327","DOI":"10.3233\/JAD-2011-101872","article-title":"Plasma fetuin-A is associated with the severity of cognitive impairment in mild-to-moderate Alzheimer's disease","volume":"24","author":"Smith","year":"2011","journal-title":"J.Alzheimers Dis."},{"key":"10.1016\/j.bbamcr.2021.119164_bb0640","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.jalz.2013.09.016","article-title":"Alzheimer's disease biomarker discovery using SOMAscan multiplexed protein technology","volume":"10","author":"Sattlecker","year":"2014","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.bbamcr.2021.119164_bb0645","doi-asserted-by":"crossref","first-page":"18851","DOI":"10.1074\/jbc.274.27.18851","article-title":"Mutagenesis identifies new signals for beta-amyloid precursor protein endocytosis, turnover, and the generation of secreted fragments, including Abeta42","volume":"274","author":"Perez","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamcr.2021.119164_bb0650","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1017\/S0317167100013949","article-title":"Early-onset familial Alzheimer's disease (EOFAD)","volume":"39","author":"Wu","year":"2012","journal-title":"Can. J. Neurol. Sci."},{"key":"10.1016\/j.bbamcr.2021.119164_bb0655","first-page":"664","article-title":"Early-onset autosomal dominant alzheimer disease.Prevalence, genetic heterogeneity, and mutation spectrum","volume":"65","author":"Campion","year":"1999"},{"key":"10.1016\/j.bbamcr.2021.119164_bb0660","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13024-017-0231-7","article-title":"Practical considerations for choosing a mouse model of Alzheimer's disease","volume":"12","author":"Jankowsky","year":"2017","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.bbamcr.2021.119164_bb0665","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.3233\/JAD-170045","article-title":"Mouse models of Alzheimer's disease","volume":"57","author":"Esquerda-Canals","year":"2017","journal-title":"J.Alzheimers Dis."},{"key":"10.1016\/j.bbamcr.2021.119164_bb0670","doi-asserted-by":"crossref","DOI":"10.1002\/cpns.81","article-title":"Overview of transgenic mouse models for Alzheimer's disease","volume":"89","author":"Myers","year":"2019","journal-title":"Curr.Protoc. Neurosci."},{"key":"10.1016\/j.bbamcr.2021.119164_bb0675","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1126\/science.274.5284.99","article-title":"Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice","volume":"274","author":"Hsiao","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.bbamcr.2021.119164_bb0680","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/ng0892-345","article-title":"A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N-terminus of beta-amyloid","volume":"1","author":"Mullan","year":"1992","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbamcr.2021.119164_bb0685","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1111\/j.1471-4159.2004.02452.x","article-title":"In vivo inhibition of Abeta production by memapsin 2 (beta-secretase) inhibitors","volume":"89","author":"Chang","year":"2004","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbamcr.2021.119164_bb0690","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0896-6273(03)00810-9","article-title":"BACE1 deficiency rescues memory deficits and cholinergic dysfunction in a mouse model of Alzheimer's disease","volume":"41","author":"Ohno","year":"2004","journal-title":"Neuron"},{"key":"10.1016\/j.bbamcr.2021.119164_bb0695","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1750-1326-10-1","article-title":"A\u03b2 reduction in BACE1 heterozygous null 5XFAD mice is associated with transgenic APP level","volume":"10","author":"Sadleir","year":"2015","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.bbamcr.2021.119164_bb0700","article-title":"Histone acetyltransferase p300 mediates histone acetylation of PS1 and BACE1 in a cellular model of Alzheimer's disease","volume":"9","author":"Lu","year":"2014","journal-title":"PloS one"},{"key":"10.1016\/j.bbamcr.2021.119164_bb0705","doi-asserted-by":"crossref","first-page":"D503","DOI":"10.1093\/nar\/gkt953","article-title":"MEROPS. The database of proteolytic enzymes, their substrates and inhibitors","volume":"42","author":"Rawlings","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bbamcr.2021.119164_bb0710","first-page":"33747","article-title":"Beta-amyloid peptide variants in brains and cerebrospinal fluid from amyloid precursor protein (APP) transgenic miceComparison with human Alzheimer amyloid","volume":"286","author":"Schieb","year":"2011"},{"key":"10.1016\/j.bbamcr.2021.119164_bb0715","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1002\/jnr.1247","article-title":"Early formation of mature amyloid-beta protein deposits in a mutant APP transgenic model depends on levels of Abeta(1\u201342)","volume":"66","author":"Rockenstein","year":"2001","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.bbamcr.2021.119164_bb0720","first-page":"32957","article-title":"High beta-secretase activity elicits neurodegeneration in transgenic mice despite reductions in amyloid-beta levelsImplications for the treatment of Alzheimer disease","volume":"280","author":"Rockenstein","year":"2005"},{"issue":"196","key":"10.1016\/j.bbamcr.2021.119164_bb0725","first-page":"e29","article-title":"Motor deficits, neuron loss, and reduced anxiety coinciding with axonal degeneration and intraneuronal A\u03b2 aggregation in the 5XFAD mouse model of Alzheimer's disease","volume":"33","author":"Jawhar","year":"2012","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.bbamcr.2021.119164_bb0730","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.3233\/JAD-143120","article-title":"Gene dosage dependent aggravation of the neurological phenotype in the 5XFAD mouse model of Alzheimer's disease","volume":"45","author":"Richard","year":"2015","journal-title":"J.Alzheimers Dis."},{"key":"10.1016\/j.bbamcr.2021.119164_bb0735","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s13024-015-0002-2","article-title":"APOE4 enhances age-dependent decline in cognitive function by down-regulating an NMDA receptor pathway in EFAD-Tg mice","volume":"10","author":"Liu","year":"2015","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.bbamcr.2021.119164_bb0740","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1084\/jem.20171529","article-title":"Humanized TREM2 mice reveal microglia-intrinsic and -extrinsic effects of R47H polymorphism","volume":"215","author":"Song","year":"2018","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bbamcr.2021.119164_bb0745","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2174\/1567205012666141218125042","article-title":"Beneficial effects of the \u03b2-secretase inhibitor GRL-8234 in 5XFAD Alzheimer's transgenic mice lessen during disease progression","volume":"12","author":"Devi","year":"2015","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.bbamcr.2021.119164_bb0750","first-page":"498","article-title":"\u03b2-secretase 1's targeting reduces hyperphosphorilated tau, implying autophagy actors in 3xTg-AD mice","volume":"9","author":"Piedrahita","year":"2015","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.bbamcr.2021.119164_bb0755","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/85059","article-title":"Mice deficient in BACE1, the Alzheimer's beta-secretase, have normal phenotype and abolished beta-amyloid generation","volume":"4","author":"Luo","year":"2001","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.bbamcr.2021.119164_bb0760","doi-asserted-by":"crossref","first-page":"11693","DOI":"10.1523\/JNEUROSCI.2766-05.2005","article-title":"BACE1, a major determinant of selective vulnerability of the brain to amyloid-beta amyloidogenesis, is essential for cognitive, emotional, and synaptic functions","volume":"25","author":"Laird","year":"2005","journal-title":"the journal of neuroscience : the official journal of the society forNeuroscience"},{"key":"10.1016\/j.bbamcr.2021.119164_bb0765","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1084\/jem.20171831","article-title":"BACE1 deletion in the adult mouse reverses preformed amyloid deposition and improves cognitive functions","volume":"215","author":"Hu","year":"2018","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bbamcr.2021.119164_bb0770","doi-asserted-by":"crossref","first-page":"827","DOI":"10.3233\/JAD-2012-111604","article-title":"Deletion of the cathepsin B gene improves memory deficits in a transgenic ALZHeimer's disease mouse model expressing A\u03b2PP containing the wild-type \u03b2-secretase site sequence","volume":"29","author":"Kindy","year":"2012","journal-title":"J.Alzheimers Dis."},{"key":"10.1016\/j.bbamcr.2021.119164_bb0775","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.biopsych.2020.02.001","article-title":"The \u03b2-secretase BACE1 in Alzheimer's disease","volume":"89","author":"Hampel","year":"2021","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.bbamcr.2021.119164_bb0780","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s40263-019-00613-7","article-title":"A close look at BACE1 inhibitors for Alzheimer's disease treatment","volume":"33","author":"Das","year":"2019","journal-title":"CNS Drugs"},{"key":"10.1016\/j.bbamcr.2021.119164_bb0785","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1002\/med.21622","article-title":"BACE1 inhibitors. Current status and future directions in treating Alzheimer's disease","volume":"40","author":"Moussa-Pacha","year":"2020","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.bbamcr.2021.119164_bb0790","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aad9704","article-title":"The BACE1 inhibitor verubecestat (MK-8931) reduces CNS \u03b2-amyloid in animal models and in Alzheimer's disease patients","volume":"8","author":"Kennedy","year":"2016","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.bbamcr.2021.119164_bb0795","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1056\/NEJMoa1812840","article-title":"Randomized trial of verubecestat for prodromal Alzheimer's disease","volume":"380","author":"Egan","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbamcr.2021.119164_bb0800","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1001\/jamaneurol.2020.4857","article-title":"Findings of efficacy, safety, and biomarker outcomes of atabecestat in preclinical Alzheimer disease. A truncated randomized phase 2b\/3 clinical trial","volume":"78","author":"Sperling","year":"2021","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.bbamcr.2021.119164_bb0805","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s13195-020-00614-5","article-title":"Long-term safety and tolerability of atabecestat (JNJ-54861911), an oral BACE1 inhibitor, in early Alzheimer's disease spectrum patients. A randomized, double-blind, placebo-controlled study and a two-period extension study","volume":"12","author":"Novak","year":"2020","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.bbamcr.2021.119164_bb0810","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1093\/brain\/awp062","article-title":"Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease. Implications for sequence of pathological events in Alzheimer's disease","volume":"132","author":"Jack","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.bbamcr.2021.119164_bb0815","first-page":"446","article-title":"11CPIB in a nondemented population.Potential antecedent marker of Alzheimer disease","volume":"67","author":"Mintun","year":"2006"},{"key":"10.1016\/j.bbamcr.2021.119164_bb0820","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1056\/NEJMoa1202753","article-title":"Clinical and biomarker changes in dominantly inherited Alzheimer's disease","volume":"367","author":"Bateman","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbamcr.2021.119164_bb0825","first-page":"311","article-title":"Anti-amyloid-\u03b2 monoclonal antibodies for Alzheimer's disease.Pitfalls and promise","volume":"83","author":"van Dyck","year":"2018"},{"key":"10.1016\/j.bbamcr.2021.119164_bb0830","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.3233\/JAD-160701","article-title":"AZD3293. Pharmacokinetic and pharmacodynamic effects in healthy subjects and patients with Alzheimer's disease","volume":"55","author":"Cebers","year":"2017","journal-title":"J. Alzheimer's disease"},{"key":"10.1016\/j.bbamcr.2021.119164_bb0835","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1002\/jcph.950","article-title":"BACE1 inhibitor lanabecestat (AZD3293) in a phase 1 study of healthy Japanese subjects. Pharmacokinetics and effects on plasma and cerebrospinal fluid A\u03b2 peptides","volume":"57","author":"Sakamoto","year":"2017","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.bbamcr.2021.119164_bb0840","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201809316","article-title":"The BACE-1 inhibitor CNP520 for prevention trials in Alzheimer's disease","volume":"10","author":"Neumann","year":"2018","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.bbamcr.2021.119164_bb0845","first-page":"202","article-title":"Profiling the dynamics of CSF and plasma A\u03b2 reduction after treatment with JNJ-54861911, a potent oral BACE inhibitor","volume":"2","author":"Timmers","year":"2016","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.bbamcr.2021.119164_bb0850","article-title":"A window into the heterogeneity of human cerebrospinal fluid A\u03b2 peptides","volume":"2011","author":"Ghidoni","year":"2011","journal-title":"J. Biomed. Biotechnol."},{"key":"10.1016\/j.bbamcr.2021.119164_bb0855","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s13195-017-0266-6","article-title":"Glutaminyl cyclase activity correlates with levels of A\u03b2 peptides and mediators of angiogenesis in cerebrospinal fluid of Alzheimer's disease patients","volume":"9","author":"Bridel","year":"2017","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.bbamcr.2021.119164_bb0860","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1038\/s41467-019-10152-w","article-title":"A\u03b234 is a BACE1-derived degradation intermediate associated with amyloid clearance and Alzheimer's disease progression","volume":"10","author":"Liebsch","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbamcr.2021.119164_bb0865","doi-asserted-by":"crossref","first-page":"3157","DOI":"10.1038\/emboj.2012.173","article-title":"Secretome protein enrichment identifies physiological BACE1 protease substrates in neurons","volume":"31","author":"Kuhn","year":"2012","journal-title":"EMBO J."},{"key":"10.1016\/j.bbamcr.2021.119164_bb0870","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1038\/nn1797","article-title":"Bace1 modulates myelination in the central and peripheral nervous system","volume":"9","author":"Hu","year":"2006","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.bbamcr.2021.119164_bb0875","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s13024-016-0134-z","article-title":"Seizure protein 6 and its homolog seizure 6-like protein are physiological substrates of BACE1 in neurons","volume":"11","author":"Pigoni","year":"2016","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.bbamcr.2021.119164_bb0880","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.neuron.2007.09.018","article-title":"Sez-6 proteins affect dendritic arborization patterns and excitability of cortical pyramidal neurons","volume":"56","author":"Gunnersen","year":"2007","journal-title":"Neuron"},{"key":"10.1016\/j.bbamcr.2021.119164_bb0885","first-page":"340","article-title":"The gp130 receptor cytokine family.Regulators of adipocyte development and function","volume":"17","author":"White","year":"2011"},{"key":"10.1016\/j.bbamcr.2021.119164_bb0890","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1159\/000511506","article-title":"Lessons learnt from the second generation of anti-amyloid monoclonal antibodies clinical trials","volume":"49","author":"Kwan","year":"2020","journal-title":"Dement. Geriatr. Cognitive disorders"},{"key":"10.1016\/j.bbamcr.2021.119164_bb0895","doi-asserted-by":"crossref","first-page":"6412","DOI":"10.1038\/s41598-018-24501-0","article-title":"Structural and kinetic basis for the selectivity of aducanumab for aggregated forms of amyloid-\u03b2","volume":"8","author":"Arndt","year":"2018","journal-title":"Sci. Rep."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Cell Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167488921002184?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167488921002184?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T19:58:41Z","timestamp":1759089521000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167488921002184"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":179,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["S0167488921002184"],"URL":"https:\/\/doi.org\/10.1016\/j.bbamcr.2021.119164","relation":{},"ISSN":["0167-4889"],"issn-type":[{"value":"0167-4889","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Swedish dilemma - the almost exclusive use of APPswe-based mouse models impedes adequate evaluation of alternative \u03b2-secretases","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Cell Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbamcr.2021.119164","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"119164"}}